Arthur Berger

BACKGROUND: The most common complication after endoscopic mucosal resection (EMR) is delayed bleeding (DB), especially in the proximal colon…

BACKGROUND: Biological treatment in inflammatory bowel disease (IBD) patients is currently hampered by high non-response rates. To enhance personalized medicine and predict response to biological therapeutics such as vedolizumab, the working mechanism should be elucidated…

Background: The adoption of endoscopic submucosal dissection (ESD) as the main option for large colorectal lesions is still limited in the West. A recent high-quality study showed colorectal ESD has been proved equally safe and more effective than piecemeal endoscopic mucosal resection (EMR)…